Cargando…
Editorial Comment: Cardiovascular Morbidity in a Randomized Trial Comparing GnRH Agonist and GnRH Antagonist among Patients with Advanced Prostate Cancer and Preexisting Cardiovascular Disease
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Sociedade Brasileira de Urologia
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7822371/ https://www.ncbi.nlm.nih.gov/pubmed/32648429 http://dx.doi.org/10.1590/S1677-5538.IBJU.2020.05.09 |
_version_ | 1783639620046553088 |
---|---|
author | Lott, Felipe |
author_facet | Lott, Felipe |
author_sort | Lott, Felipe |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-7822371 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Sociedade Brasileira de Urologia |
record_format | MEDLINE/PubMed |
spelling | pubmed-78223712021-01-23 Editorial Comment: Cardiovascular Morbidity in a Randomized Trial Comparing GnRH Agonist and GnRH Antagonist among Patients with Advanced Prostate Cancer and Preexisting Cardiovascular Disease Lott, Felipe Int Braz J Urol Update in Urology Sociedade Brasileira de Urologia 2020-07-31 /pmc/articles/PMC7822371/ /pubmed/32648429 http://dx.doi.org/10.1590/S1677-5538.IBJU.2020.05.09 Text en https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Update in Urology Lott, Felipe Editorial Comment: Cardiovascular Morbidity in a Randomized Trial Comparing GnRH Agonist and GnRH Antagonist among Patients with Advanced Prostate Cancer and Preexisting Cardiovascular Disease |
title | Editorial Comment: Cardiovascular Morbidity in a Randomized Trial Comparing GnRH Agonist and GnRH Antagonist among Patients with Advanced Prostate Cancer and Preexisting Cardiovascular Disease |
title_full | Editorial Comment: Cardiovascular Morbidity in a Randomized Trial Comparing GnRH Agonist and GnRH Antagonist among Patients with Advanced Prostate Cancer and Preexisting Cardiovascular Disease |
title_fullStr | Editorial Comment: Cardiovascular Morbidity in a Randomized Trial Comparing GnRH Agonist and GnRH Antagonist among Patients with Advanced Prostate Cancer and Preexisting Cardiovascular Disease |
title_full_unstemmed | Editorial Comment: Cardiovascular Morbidity in a Randomized Trial Comparing GnRH Agonist and GnRH Antagonist among Patients with Advanced Prostate Cancer and Preexisting Cardiovascular Disease |
title_short | Editorial Comment: Cardiovascular Morbidity in a Randomized Trial Comparing GnRH Agonist and GnRH Antagonist among Patients with Advanced Prostate Cancer and Preexisting Cardiovascular Disease |
title_sort | editorial comment: cardiovascular morbidity in a randomized trial comparing gnrh agonist and gnrh antagonist among patients with advanced prostate cancer and preexisting cardiovascular disease |
topic | Update in Urology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7822371/ https://www.ncbi.nlm.nih.gov/pubmed/32648429 http://dx.doi.org/10.1590/S1677-5538.IBJU.2020.05.09 |
work_keys_str_mv | AT lottfelipe editorialcommentcardiovascularmorbidityinarandomizedtrialcomparinggnrhagonistandgnrhantagonistamongpatientswithadvancedprostatecancerandpreexistingcardiovasculardisease |